Jeff Yass’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
Jeff Yass's HQL Position: Q3 2026 in Review
Jeff Yass opened a new position in abrdn Life Sciences Investors (HQL) in Q3 2026: 11,246 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #11835 among its holdings. This is a return to the name: Jeff Yass previously reported a position in HQL as recently as Q3 2014.
Jeff Yass first reported a position in HQL in Q2 2014 and has held it in 3 quarters since. The position peaked at $4.71M in Q2 2014. 82 funds tracked by Wall St. Rank hold HQL as of Q3 2026.
- Jeff Yass held 11,246 shares of abrdn Life Sciences Investors worth $210K as of Q3 2026.
- abrdn Life Sciences Investors was a new Jeff Yass position in Q3 2026.
- abrdn Life Sciences Investors made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11835 holding.
- Jeff Yass first reported a position in abrdn Life Sciences Investors in Q2 2014 and has held it in 3 quarters since.
- Jeff Yass's abrdn Life Sciences Investors position peaked at $4.71M in Q2 2014.
- 82 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.